News & Events
Join Us at Upcoming Events
|January 28, 2018||January 29, 2018||January 30, 2018||January 31, 2018||February 1, 2018||February 2, 2018||February 3, 2018|
|February 4, 2018||February 5, 2018||February 6, 2018||February 7, 2018||February 8, 2018||February 9, 2018||February 10, 2018|
|February 11, 2018||February 12, 2018||February 13, 2018||February 14, 2018||February 15, 2018||February 16, 2018||February 17, 2018|
|February 18, 2018||February 19, 2018||February 20, 2018||February 21, 2018||February 22, 2018||February 23, 2018||February 24, 2018|
|February 25, 2018||February 26, 2018||February 27, 2018||February 28, 2018||March 1, 2018||March 2, 2018||March 3, 2018|
30 January – 2 February 2018
20-23 February 2018
American Venous Forum
24-27 April 2018
Charing X Symposium
London, United Kingdom
28-30 June 2018
European Venous Forum
Agreement Provides Physicians with Greater Access to Dedicated Venous Stent Technology
08 Sept 2016 – VENITI® Closes on $25M from Boston Scientific
VENITI, Inc., a leader in the advancement of treatment for deep venous disease, has closed on $25 million in Series D equity financing from Boston
Venous stent designed specifically for the challenges of the venous system achieves adoption milestone
13-14 May 2016 – VENITI®’s will present on Venous Stents at the ESVS Spring Meeting in London, UK
26-29 April 2016 – VENITI® will present the VIRTUS Trial Update at Charing Cross in London, UK
– VIRTUS Trial Update – Lowell S. Kabnick, MD, RPhS, NYU Langone MC, New York, NY
22 April 2016 – VENITI® Completes First Use Of VICI VERTO VENOUS STENT™, Novel Venous Stent System
17-21 November 2015 – VENITI® will attend the 2015 VEITH symposium in New York, NY
3:46pm – 3:51 pm Tuesday, 17 November 2015 – Early Experience With The VENITI VICI VENOUS STENT And Update On The VIRTUS Trial, William Marston, MD, University of NC, Chapel Hill, NC
10:05am – 10:10am Thursday, 19 November 2015 – VIRTUS: An Evaluation of the VICI VENOUS STENT System In Patients with Chronic Iliofemoral Venous Outflow Obstruction, Mikel Sadek, MD, NYU Langone MC, New York, NY
10:29am – 10:34am Thursday, 19 November 2015 – Luncheon Symposium – Comprehensive Review of Venous Outflow Obstruction: Diagnosis, Care Pathway and Treatment
12pm – 1pm Friday, 20 November 2015 – What is the Ideal Venous Stent, Lowell Kabnick, MD, NYU Langone MC, New York, NY
10 March 2015 – VENITI®, Inc. Announces Closing of Equity and Debt Funding
9 February 2015 – Frost & Sullivan Applauds VENITI’s Dedication to Improving the Treatment of Chronic Venous Diseases (CVD) through Unique and Differentiated Products
11 January 2015 – First Patients Treated in Germany with VENITI® VICI VENOUS STENT System ®
5 January 2015 – The VIRTUS Trial for the VENITI® VICI Venous Stent System
Percutaneous stenting of the iliofemoral venous outflow system has evolved in to the preferred approach for management of chronic venous obstruction. The procedure can be performed with low morbidity, low mortality, long-term high patency rate, and low rate of in-stent restenosis.
1 December 2014 – VENITI®, Inc. Announces First U.S. Patients Enrolled in VIRTUS Trial
VENITI, Inc., a company dedicated to advancing the treatment of venous disease, announced that it has enrolled the first United States patients in the VIRTUS trial of the VENITI VICI™ Venous Stent System. The four procedures were performed at two sites, including the Heart and Vascular Center, St. Joseph Hospital, Orange, CA.
14 July 2014 – VENITI®, Inc. Announces FDA Approval of IDE for VENITI VICI™ Venous Stent System, First Patients Enrolled in VIRTUS Trial
VENITI, Inc., a company dedicated to providing innovative technology for the treatment of venous disease, announced that it has received approval from the United States Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) to begin the VIRTUS trial of the VENITI VICI Venous Stent System.
23 January 2014 – VENITI®, Inc. Announces First Uses of Veniti Vici Venous Stent System
VENITI announced today that patients in the European Union (EU) were successfully treated for symptomatic venous outflow obstruction of the lower extremities with the Veniti Vici™ Venous Stent System. These procedures mark the first uses in patients of this novel Venous Stent from VENITI.
6 November 2013 – VENITI® Receives CE Mark Approval for Vici Venous Stent
Veniti Inc. has received approval to CE Mark the Veniti Vici™ Venous Stent, specifically designed for the treatment of adult patients who exhibit systematic venous outflow obstruction. The CE Mark allows Veniti to sell products within the European Union.
We are eager to answer them. Call us directly or submit the convenient online form below.